GKB Ophthalmics Limited

BSE:533212 Stock Report

Market Cap: ₹501.7m

GKB Ophthalmics Past Earnings Performance

Past criteria checks 0/6

GKB Ophthalmics's earnings have been declining at an average annual rate of -10.9%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 11.9% per year.

Key information

-10.9%

Earnings growth rate

-9.9%

EPS growth rate

Medical Equipment Industry Growth23.0%
Revenue growth rate11.9%
Return on equity-5.4%
Net Margin-3.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How GKB Ophthalmics makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:533212 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24978-361830
30 Jun 24920-361730
31 Mar 24883-281620
31 Dec 23867-381500
30 Sep 23817-361420
30 Jun 23799-161140
31 Mar 23755-21330
31 Dec 22730241110
30 Sep 22734431070
30 Jun 22734311010
31 Mar 22709131120
31 Dec 21707171060
30 Sep 21681101030
30 Jun 2164911840
31 Mar 21569-9800
31 Dec 20557-21860
30 Sep 20545-22850
30 Jun 20526-32880
31 Mar 20585-18930
31 Dec 19576-3990
30 Sep 19540-231020
30 Jun 19546-14880
31 Mar 19574-111070
31 Mar 18774-101030
31 Mar 1774126980
31 Mar 1643840730
31 Mar 153520730
31 Mar 1441540740

Quality Earnings: 533212 is currently unprofitable.

Growing Profit Margin: 533212 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 533212 is unprofitable, and losses have increased over the past 5 years at a rate of 10.9% per year.

Accelerating Growth: Unable to compare 533212's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 533212 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (8.8%).

Return on Equity

High ROE: 533212 has a negative Return on Equity (-5.36%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 09:56
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GKB Ophthalmics Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution